Therapy
Reporting and commentary on guideline-directed medical therapies, including recent studies on heart failure management, telehealth delivery of care, and pharmaceutical interventions.
PBBK 1 gathers and summarises medical news, research summaries, and commentary on therapy topics for healthcare professionals, patients, and readers interested in medical research and policy. Articles are written by Richard A. Banks.
This section tracks how established treatments are studied, delivered, and regulated. Coverage includes comparisons between in-person and telehealth follow-up, the use of potassium binders in heart failure with reduced ejection fraction, and wider market research on complementary and alternative medicine.
Nothing published here is medical advice, diagnosis, or a substitute for consultation with a qualified clinician.
The medical therapy section of this site collects and condenses reporting on medicine, treatment, and healthcare for professionals, patients, and curious readers. Rather than offering prescriptions or clinical direction, the coverage explains how established therapies are studied, delivered, and regulated, including comparisons between in-person visits and remote telehealth follow-up. The tone is informational and cautious, aiming to help readers understand the evidence and the practical trade-offs behind common therapeutic decisions, from chronic disease management to post-operative care.
Beyond clinical topics, the section also widens its lens to industry and policy questions, tracking market research on complementary and alternative medicine, research into drug resistance, and the effect of regulatory and legal frameworks on access to care. Reports reference work by doctors, practitioners, and institutes, along with analysis of how hospitals, insurers, and governments shape treatment availability for families and underserved groups. As with all material published here, the summaries are intended as background reading rather than medical advice, and readers are encouraged to consult qualified clinicians about individual care.
Filed March 23, 2022
How outpatient management of guideline-directed medical therapy for heart failure was compared across office, video, and telephone visits, including what the study examined and what it reported.
What this section follows
| Theme | Example coverage |
|---|---|
| Telehealth delivery of care | Comparison of office, video, and telephone visits for outpatient heart failure management |
| Pharmacological intervention | Patiromer and prevention of hyperkalemia in HFrEF, supporting optimal medical therapy |
| Guideline updates | Peripheral arterial disease guidelines and serial NT-proBNP levels in guided therapy for HFrEF |
| Market research | Complementary and alternative medicine market research analysis, posted May 2, 2022 |
Older entries remain browsable by month and year, covering material from December 1993 through January 2019.
See all archived articles or continue to alternative medicine insights.
Guideline-directed medical therapy, heart failure management, telehealth follow-up, and drug interventions.
Market analysis and regulatory coverage of complementary and alternative medicine.
Commentary on healthcare policy, ethics in treatment, and access to care.